Skip to main content

Table 4 The detailed database information on APOA5 variants

From: The pathogenic mutations of APOA5 in Chinese patients with hyperlipidemic acute pancreatitis

APOA5 Variant

             

HLAP group

BAP group

Gene location

Nucleotide change

Protein change

SNP a

variant

SIFTb

Polyphen2-HDIVc

LRTd

Mutation Tastere

Mutation Assessorf

CADDg

GnomAD-ALLh

GnomAD-EASi

GnomAD-AMRj

phylo-HMMk

References

status

N

TG

N

TG

pathogenic mutations

 exon2

c.104G > A

p.S35N

rs184390502

known

D

P

N

N

M

21

5.35E-05

6.69E-04

0.00E + 00

0.046

 

het

1

29.83

0

na

 exon3

c.500A > T

p.D167V

rs762999453

known

D

B

N

D

M

20.9

4.00E-06

5.45E-05

0.00E + 00

0.419

 

het

1

21.8

0

na

 exon3

c.553G > T

p.G185C

rs2075291

known

D

D

N

N

M

24.5

6.23E-03

6.77E-02

2.83E-04

-0.055

[39]

het

42

15.43 ± 16.89

1

1.06

 

hom

7

10.77 ± 8.31

0

na

 exon3

c.563A > T

p.K188I

na

novel

D

P

N

N

M

22.2

na

na

na

-0.033

 

het

1

13.42

0

na

 exon3

c.667C > T

p.R223C

na

novel

D

D

D

D

M

29

na

na

na

0.419

 

het

1

16.75

0

na

 exon3

c.544_545 insGGTGC

p.H182fs

na

novel

na

na

na

na

na

na

na

na

na

na

 

het

1

9.56

0

na

Benign mutations

 exon2

c.77G > T

p.G26V

rs548745995

known

T

P

N

D

M

24

4.15E-06

5.62E-05

0.00E + 00

0.514

 

het

0

na

1

0.74

 exon3

c.457G > A

p.V153M

rs3135507

known

T

B

N

P

L

13.66

5.09E-02

1.19E-01

4.59E-02

0.43

[40]

het

47

20.32 ± 19.55

10

0.88 ± 0.24

 

hom

5

19.18 ± 22.99

1

0.71

 exon3

c.538G > C

p.V180L

rs753800578

known

T

B

N

N

M

17.37

2.41E-05

3.29E-04

0.00E + 00

-0.042

[41]

het

0

na

1

0.81

 exon3

c.788G > A

p.G263D

na

novel

T

B

N

N

L

1.838

na

na

na

-0.042

 

het

1

108.75

0

na

  1. het heterozygote, hom: homozygote, N number of people carrying the mutation in the group
  2. aThe number of mutations in the dbSNP (v147), na not available
  3. bSIFT, D: deleterious, T: tolerated
  4. cPolyphen2-HDIV, D probably damaging, P possibly damaging, B benign
  5. dLRT, D: deleterious, N neutral, U unknown
  6. eMutation Taster, D disease causing, N polymorphism, P polymorphism automatic
  7. fMutation Assessor, high (H) and medium (M) are damaging, and low (L) and neutral (N) are benign
  8. gCADD > 15 is deleterious, ≥ 20 is anticipated to be ranked among the top 1% of the most deleterious mutations in the human genome
  9. h−jThe allele frequency (%) in total / East Asian / Latin American populations from gnomAD
  10. kThe phylo-HMM model assesses the conservation of residues in 20 mammalian species; the higher the score, the greater the conservation